Under construction – not a live service
Sign in
Taking people in MaliNo phase

Checks whether clinics can follow kidney tumor treatment plans for children

Observes how clinics follow treatment steps for children with kidney cancer.

Plain-language title generated from the registry record
Registry title: Therapeutic Recommendations for Nephroblastoma

Key facts

Where
Bamako, MaliSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children with a kidney tumour called nephroblastoma, in one kidney only, who have not had treatment yet and are well enough to be treated.

Age
6 Months to 18 Years
Sex
Girls and boys can join.
Disease stage
Nephroblastoma (kidney tumour) in one kidney only. The disease must not be too advanced.
Earlier treatment
The child must not have been treated before.

Main reasons for not taking part

  • Tumour in both kidneys
  • Already treated before
  • Disease too advanced
  • Doubt about the diagnosis
  • Treatment refused

Read by machine on 9 November 2026.

Where in Mali

  • CHU Gabriel Touré (HGT)Bamako, MaliContact: Boubacar TOGO, PROFESSEURTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
French Africa Pediatric Oncology Group
Trial code
NCT04423484
Record updated
2 March 2026
Original description
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.Read full original descriptionShow less

Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Inclusion: Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment.

Exclusion: Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal.

ClinicalTrials.gov NCT04423484